Spectral Medical Inc (EDT):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Spectral Medical Inc (EDT) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C12338
◆発行会社(調査会社):GlobalData
◆発行日:2018年12月
◆ページ数:30
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Spectral Medical Inc (Spectral), formerly Spectral Diagnostics Inc, is a biotechnology company that develops and commercializes diagnostic solutions for patient management. The company’s products comprise EAA, toraymyxin and reagents, among others. Its EAA is an endotoxin activity assay, which is used as diagnostic for endotoxemia. Spectral’s toraymyxin is a polymyxin B extracorporeal direct hemoperfusion adsorption column that is used in removing endotoxin in the bloodstream. The company’s toraymyxin is used for the treatment of patients with septic shock. It also conducts research and development, clinical investigation and validation studies on its products under development. Spectral is headquartered in Toronto, Ontario, Canada.

Spectral Medical Inc (EDT) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Spectral Medical Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Spectral Medical Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Spectral Medical Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Spectral Medical Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Spectral Medical Inc, Medical Devices Deals, 2012 to YTD 2018 9
Spectral Medical Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Spectral Medical Inc, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Spectral Medical Enters into Agreement with Fresenius Medical Care Deutschland 11
Equity Offering 12
Spectral Medical Raises USD4.1 Million in Private Placement of Units 12
Spectral Diagnostics Raises USD4.7 Million in Second Tranche of Private Placement of Shares 13
Spectral Diagnostics Raises USD12 Million in First Tranche of Private Placement of Shares 15
Spectral Medical Inc – Key Competitors 17
Spectral Medical Inc – Key Employees 18
Spectral Medical Inc – Locations And Subsidiaries 19
Head Office 19
Recent Developments 20
Financial Announcements 20
Nov 14, 2018: Spectral announces third quarter results 20
Aug 14, 2018: Spectral reports second quarter 2018 financial results 21
May 11, 2018: Spectral Announces First Quarter 2018 Results 22
Mar 29, 2018: Spectral Announces Fourth Quarter and Fiscal 2017 Results 23
Nov 14, 2017: Spectral Announces Third Quarter Results 24
Aug 11, 2017: Spectral Announces Second Quarter Results 25
May 12, 2017: Spectral Announces First Quarter Results 26
Mar 30, 2017: Spectral Announces Fourth Quarter and Fiscal 2016 Results 27
Corporate Communications 28
Feb 01, 2018: Spectral Medical Announces the Appointment of Chief Financial Officer 28
Oct 18, 2017: Spectral Announces Retirement of Chief Financial Officer 29
Appendix 30
Methodology 30
About GlobalData 30
Contact Us 30
Disclaimer 30

List of Tables
Spectral Medical Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Spectral Medical Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Spectral Medical Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Spectral Medical Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Spectral Medical Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Spectral Medical Inc, Medical Devices Deals, 2012 to YTD 2018 9
Spectral Medical Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Spectral Medical Enters into Agreement with Fresenius Medical Care Deutschland 11
Spectral Medical Raises USD4.1 Million in Private Placement of Units 12
Spectral Diagnostics Raises USD4.7 Million in Second Tranche of Private Placement of Shares 13
Spectral Diagnostics Raises USD12 Million in First Tranche of Private Placement of Shares 15
Spectral Medical Inc, Key Competitors 17
Spectral Medical Inc, Key Employees 18

List of Figures
Spectral Medical Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Spectral Medical Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Spectral Medical Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Spectral Medical Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Spectral Medical Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Spectral Medical Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Spectral Medical Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Spectral Medical Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Spectral Medical Inc, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Spectral Medical Inc (EDT):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Biocept Inc (BIOC):企業の財務・戦略的SWOT分析
    Summary Biocept Inc (Biocept) is a molecular diagnostics company. The company develops and commercializes proprietary circulating tumor cell (CTC) and circulating tumor DNA assays utilizing a standard blood sample. It offers assays for solid tumor indications, such as breast cancer, non-small cell l …
  • Mercantil Bank, N.A.:企業の戦略・SWOT・財務情報
    Mercantil Bank, N.A. - Strategy, SWOT and Corporate Finance Report Summary Mercantil Bank, N.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • MetLife Inc:戦略・SWOT・企業財務分析
    MetLife Inc - Strategy, SWOT and Corporate Finance Report Summary MetLife Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • The Kansai Electric Power Co, Incorporated:企業の戦略・SWOT・財務分析
    The Kansai Electric Power Co, Incorporated - Strategy, SWOT and Corporate Finance Report Summary The Kansai Electric Power Co, Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, …
  • DiGi.Com Berhad (DIGI):企業の財務・戦略的SWOT分析
    DiGi.Com Berhad (DIGI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Acacia Mining Plc:企業の戦略・SWOT・財務情報
    Acacia Mining Plc - Strategy, SWOT and Corporate Finance Report Summary Acacia Mining Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Hebei Construction Group Co Ltd (1727):企業の財務・戦略的SWOT分析
    Hebei Construction Group Co Ltd (1727) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • Kurabo Industries Ltd (3106):企業の財務・戦略的SWOT分析
    Kurabo Industries Ltd (3106) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Jakks Pacific, Inc.
    Jakks Pacific, Inc. - Strategy, SWOT and Corporate Finance Report Summary Jakks Pacific, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • BrainScope Company Inc:医療機器:M&Aディール及び事業提携情報
    Summary BrainScope Company Inc (BrainScope) is a medical device company that offers medical neurotechnology products. The company develops and distributes non-invasive instruments for the treatment of traumatic brain injuries, moderate traumatic brain injury and mild traumatic brain injury. It provi …
  • The Timken Co (TKR):電力:M&Aディール及び事業提携情報
    Summary The Timken Co (Timken) is an industrial technology company that develops, produces and sells mechanical components. The company offers engineered bearings, mechanical power transmission products, switch gears and electric motors and generators. Timken also offers remanufacture and repair, ma …
  • Chevron Corporation (CVX)-エネルギー分野:企業M&A・提携分析
    Summary Chevron Corporation (Chevron) is an integrated oil and gas company. It operates in the oil and gas value chain from exploration and production, storage and pipeline transportation to refining, marketing and distribution of oil and gas products. Chevron explores for produces and transports cr …
  • Mohawk Industries, Inc.:企業の戦略・SWOT・財務情報
    Mohawk Industries, Inc. - Strategy, SWOT and Corporate Finance Report Summary Mohawk Industries, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Schroders Plc
    Schroders Plc - Strategy, SWOT and Corporate Finance Report Summary Schroders Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Litha Healthcare Group Ltd-医療機器分野:企業M&A・提携分析
    Summary Litha Healthcare Group Ltd (Litha Healthcare), formerly Myriad Medical Holdings Limited, a subsidiary of Endo International plc is a healthcare company that provides its services to public and private hospitals, pharmacies, general, allied practitioners, and government healthcare programmes. …
  • Berkshire Hills Bancorp, Inc.:企業のM&A・事業提携・投資動向
    Berkshire Hills Bancorp, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Berkshire Hills Bancorp, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and …
  • Implants International Ltd:企業の製品パイプライン分析
    Summary Implants International Ltd (Implants International) is a medical device company that manufactures, designs, and develops orthopedic implants, bio-engineering, and other products for the healthcare sector. The company’s products include revision systems, hip stems, hip stem ancillaries, aceta …
  • George Weston Limited:企業の戦略・SWOT・財務情報
    George Weston Limited - Strategy, SWOT and Corporate Finance Report Summary George Weston Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Stryker Corporation:企業の戦略・SWOT・財務情報
    Stryker Corporation - Strategy, SWOT and Corporate Finance Report Summary Stryker Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Sygnature Discovery Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Sygnature Discovery Ltd (Sygnature) is a drug discovery company that offers medicinal chemistry, bioscience, computational chemistry, and fragment-based drug discovery programs. The company offers services for various phases of drug discovery which include hit identification, hit to lead, an …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆